Is Debiopharm Research & Manufacturing SA FDA approved?

Debiopharm Research & Manufacturing SA holds 1 FDA-registered establishment in Switzerland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Debiopharm Research & Manufacturing SA's drugs manufactured?

The FDA register lists Martigny. Registered operations: analytical testing, finished drug manufacture.

What drugs does Debiopharm Research & Manufacturing SA make?

4 products are listed under Debiopharm Research & Manufacturing SA in the openFDA NDC Directory, most often as injection, powder, for suspension; injection, powder, for suspension, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Debiopharm Research & Manufacturing SA

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 4
Live patents: 0
Countries: 1
Base: Switzerland

Authorisation

Registered operations

Analytical testing1Finished drug manufacture1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Debiopharm Research & Manufacturing SA	Rue du Levant 146, Martigny, VS 1920, Switzerland (CHE)	Analytical testing, Finished drug manufacture	3002806850481942860

Catalogue

Drug listings by form and route

4 active NDC listings: 4 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 4.

Dosage form	NDCs
injection, powder, for suspension	3
injection, powder, for suspension, extended release	1

Route	NDCs

Labeller name on the listing	NDCs
debiopharm research & manufacturing sa	4

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	Triptorelin Pamoate	injection, powder, for suspension	62788-437DRUG FOR FURTHER PROCESSING
-	Triptorelin pamoate	injection, powder, for suspension	62788-288DRUG FOR FURTHER PROCESSING
-	Triptorelin pamoate	injection, powder, for suspension	62788-715DRUG FOR FURTHER PROCESSING
-	Triptorelin pamoate	injection, powder, for suspension, extended release	62788-956DRUG FOR FURTHER PROCESSING

Compare

Comparable companies in Switzerland

Ricola Ag1 site · 84 NDC
Avyxa GmbH1 site · 29 NDC
Bachem AG1 site · 23 NDC
Vifor (International) AG1 site · 22 NDC
DOTTIKON EXCLUSIVE SYNTHESIS AG1 site · 16 NDC
HAS Healthcare Advanced Synthesis SA1 site · 11 NDC
Cerbios-Pharma SA1 site · 9 NDC
SINTETICA S.A.1 site · 9 NDC
Similasan AG1 site · 7 NDC
Swiss Caps AG1 site · 6 NDC

Enquiry

Common questions

Is Debiopharm Research & Manufacturing SA FDA approved?: Debiopharm Research & Manufacturing SA holds 1 FDA-registered establishment in Switzerland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Debiopharm Research & Manufacturing SA's drugs manufactured?: The FDA register lists Martigny. Registered operations: analytical testing, finished drug manufacture.
What drugs does Debiopharm Research & Manufacturing SA make?: 4 products are listed under Debiopharm Research & Manufacturing SA in the openFDA NDC Directory, most often as injection, powder, for suspension; injection, powder, for suspension, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.